Azficel-T
| Clinical data | |
|---|---|
| Trade names | Laviv |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration | Intradermal |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| DrugBank | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
Azficel-T, sold under the brand name Laviv, is a cell therapy product used to treat moderate to severe nasolabial fold wrinkles (the lines running from the sides of the nose to the corners of the mouth) in adults.[1]
The treatment is autologous, meaning it uses the patient’s own cells. Specifically, fibroblasts—cells involved in skin structure and repair—are extracted from a small skin sample, cultured in a laboratory to increase their number, and then re-injected into the patient’s skin to improve appearance.[2]
Azficel-T was approved for medical use in the United States in June 2011.[2]
References
[edit | edit source]Further reading
[edit | edit source]- Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
External links
[edit | edit source]- Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- Clinical trial number NCT02120781 for "Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia" at ClinicalTrials.gov
Lua error in mw.title.lua at line 392: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal'). Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).
